These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 4043173)

  • 1. Activity of titanocene dihalides against a human colon carcinoma heterotransplanted to athymic mice.
    Köpf-Maier P; Moormann A; Köpf H
    Eur J Cancer Clin Oncol; 1985 Jul; 21(7):853-7. PubMed ID: 4043173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antitumor activity of titanocene dichloride in xenografted human renal-cell carcinoma.
    Köpf-Maier P
    Anticancer Res; 1999; 19(1A):493-504. PubMed ID: 10226588
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor inhibition by titanocene complexes: influence upon two xenografted human lung carcinomas.
    Köpf-Maier P
    J Cancer Res Clin Oncol; 1987; 113(4):342-8. PubMed ID: 3036884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumor inhibition by titanocene complexes: activity against sarcoma 180.
    Köpf-Maier P; Preiss F; Marx T; Klapötke T; Köpf H
    Anticancer Res; 1986; 6(1):33-7. PubMed ID: 3954328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor inhibition by titanocene complexes: influence on xenografted human adenocarcinomas of the gastrointestinal tract.
    Köpf-Maier P
    Cancer Chemother Pharmacol; 1989; 23(4):225-30. PubMed ID: 2924380
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor metallocenes: new developments and toxicologic features.
    Köpf-Maier P; Köpf H
    Anticancer Res; 1986; 6(2):227-33. PubMed ID: 3707060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor inhibition by metallocenes: antitumor activity of titanocene dihalides (C5H5)2TiX2 (X=F, Cl, Br, I, NCS) and their application in buffered solutions as a method for suppressing drug-induced side effects.
    Köpf-Maier P; Hesse B; Voigtländer R; Köpf H
    J Cancer Res Clin Oncol; 1980; 97(1):31-9. PubMed ID: 7400205
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytokinetic behavior of Ehrlich ascites tumor after in vivo treatment with cis-diamminedichloroplatinum(II) and metallocene dichlorides.
    Köpf-Maier P; Wagner W; Liss E
    J Cancer Res Clin Oncol; 1981; 102(1):21-30. PubMed ID: 7199526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunologic response to the treatment of Ehrlich ascites tumor with titanocene dichloride.
    Köpf-Maier P; Hesse A
    J Cancer Res Clin Oncol; 1984; 108(2):254-5. PubMed ID: 6540782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with titanocene dichloride.
    Köpf-Maier P
    J Cancer Res Clin Oncol; 1988; 114(3):250-8. PubMed ID: 3384842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intracellular localization of titanium within xenografted sensitive human tumors after treatment with the antitumor agent titanocene dichloride.
    Köpf-Maier P
    J Struct Biol; 1990; 105(1-3):35-45. PubMed ID: 2100149
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor activity of Titanocene Y against freshly explanted human breast tumor cells and in xenografted MCF-7 tumors in mice.
    Beckhove P; Oberschmidt O; Hanauske AR; Pampillón C; Schirrmacher V; Sweeney NJ; Strohfeldt K; Tacke M
    Anticancer Drugs; 2007 Mar; 18(3):311-5. PubMed ID: 17264764
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organ toxicity of metallocene dichlorides. The effect of (C5H5)2TiCl2 and (C5H5)2VCl2 on renal structure.
    Köpf-Maier P; Funke-Kaiser P
    Toxicology; 1986 Jan; 38(1):81-90. PubMed ID: 3942012
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preclinical evaluation of diethoxy-(1-phenyl-1,3-butanedionato) titanium (IV) in human tumour xenografts.
    Mattern J; Keppler B; Volm M
    Arzneimittelforschung; 1984; 34(10):1289-90. PubMed ID: 6549134
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumour activity of [1,2-di(cyclopentadienyl)-1,2-di(p-N,N-dimethylaminophenyl)-ethanediyl] titanium dichloride in xenografted Ehrlich's ascites tumour.
    Valadares MC; Ramos AL; Rehmann FJ; Sweeney NJ; Strohfeldt K; Tacke M; Queiroz ML
    Eur J Pharmacol; 2006 Mar; 534(1-3):264-70. PubMed ID: 16513106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Titanocene dichloride--the first metallocene with cancerostatic activity.
    Köpf H; Köpf-Maier P
    Angew Chem Int Ed Engl; 1979 Jun; 18(6):477-8. PubMed ID: 111586
    [No Abstract]   [Full Text] [Related]  

  • 17. Antitumor activity of cis-malonato[(4R,5R)-4,5-bis(aminomethyl)-2- isopropyl-1,3-dioxolane]platinum(II), a new platinum analogue, as an anticancer agent.
    Kim DK; Kim HT; Cho YB; Tai JH; Ahn JS; Kim TS; Kim KH; Hong WS
    Cancer Chemother Pharmacol; 1995; 35(5):441-5. PubMed ID: 7850928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human ovarian cancer xenografts in nude mice: chemotherapy trials with paclitaxel, cisplatin, vinorelbine and titanocene dichloride.
    Villena-Heinsen C; Friedrich M; Ertan AK; Farnhammer C; Schmidt W
    Anticancer Drugs; 1998 Jul; 9(6):557-63. PubMed ID: 9877245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human tumour xenografts in nude mice: chemotherapy trials with titanocene dichloride in different dosages.
    Villena-Heinsen C; Friedrich M; Ertan AK; Schmidt W
    Clin Exp Obstet Gynecol; 1998; 25(1-2):5-8. PubMed ID: 9743868
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In-vitro anti-tumor activity studies of bridged and unbridged benzyl-substituted titanocenes.
    Kelter G; Sweeney NJ; Strohfeldt K; Fiebig HH; Tacke M
    Anticancer Drugs; 2005 Nov; 16(10):1091-8. PubMed ID: 16222151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.